For decades, Parkinson’s disease has been diagnosed only after tremors, stiffness and slowed movement are already disrupting daily life. Now a wave of research suggests a simple blood draw could ...
Add Yahoo as a preferred source to see more of our stories on Google. A new, simple blood test developed by Israeli researchers could allow Parkinson's disease sufferers to get an early warning before ...
SUN CITY, Ariz. — For Drs. Charles Adler and Thomas Beach, one of the most difficult parts of diagnosing Parkinson’s disease is that they could be wrong. “There is no test, so we don’t have any way of ...
A new blood test could reveal Parkinson’s diagnoses up to seven years before symptoms emerge. Researchers from University College London and University Medical Center Goettingen in Germany used ...
A team of researchers, led by scientists at UCL and University Medical Center Goettingen, have developed a simple blood test that uses artificial intelligence (AI) to predict Parkinson’s up to seven ...
Kinetic measures of a cerebrospinal fluid (CSF) biomarker test predicted cognitive decline in Parkinson's disease and distinguished it from progressive supranuclear palsy (PSP), an analysis of data ...
A revolutionary new blood test may be able to identify Parkinson’s disease up to seven years before symptoms appear, according to a study published this week in the journal Nature Communcations. This ...
More than a million people in the U.S. are living with Parkinson’s disease. Some who have it don’t even know it. There is no definitive test to diagnose it, and often, it’s only treated after patients ...
An automated assessment technique that uses artificial intelligence could revolutionize the management of Parkinson's disease. A video-processing technique developed at the University of Florida that ...
Skin biopsies detected phosphorylated alpha-synuclein in a high proportion of people with Parkinson's disease and other synucleinopathies. Finding a reliable diagnostic biomarker for synucleinopathies ...
Faster CSF alpha-synuclein seeding kinetics predicted cognitive decline in Parkinson's in multiple cohorts. GBA1-associated Parkinson's exhibited quicker seeding kinetics than sporadic Parkinson's ...
Scientists have developed a simple blood test that uses artificial intelligence (AI) to predict Parkinson's up to seven years before the onset of symptoms. A team of researchers, led by scientists at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results